Maria Dobek serves as Vice President, Accounting at Janux Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Maria Dobek has executed 3 insider transactions totaling $20.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 42,600 shares valued at $0.
Maria Dobek currently holds 42,600 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $0. This represents their equity stake as Vice President, Accounting.
Based on SEC Form 4 filings, Maria Dobek has been a net seller of JANX stock. They have purchased $0 and sold $20.1K worth of shares.
Maria Dobek's most recent insider trade was on Jan 2, 2026, when they sold 42,600 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 2, 2026 | JANX | $20.1K | Sale | 1,462 | $13.73 | Discretionary |